Bowen Hanes & Co
LLY icon

Bowen Hanes & Co’s Eli Lilly LLY Stock Holding History

Bowen Hanes & Co’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$132M Sell
114,081
-565
-0.5% -$667K 2.98% 7
2026
Q2 		$105M Hold
114,646
– – 2.57% 7
2026
Q1 		$105M Sell
114,646
-648
-0.6% -$657K 2.57% 7
2025
Q4 		$124M Sell
115,294
-2,016
-2% -$1.93M 3.11% 5
2025
Q3 		$89.5M Sell
117,310
-10,930
-9% -$8.13M 2.24% 12
2025
Q2 		$100M Buy
128,240
+185
+0.1% +$144K 2.52% 10
2025
Q1 		$106M Sell
128,055
-495
-0.4% -$412K 2.94% 4
2024
Q4 		$99.2M Buy
128,550
+3,236
+3% +$2.68M 2.66% 7
2024
Q3 		$111M Sell
125,314
-503
-0.4% -$452K 2.91% 4
2024
Q2 		$114M Sell
125,817
-10,683
-8% -$8.55M 3.16% 2
2024
Q1 		$106M Sell
136,500
-4,454
-3% -$3.17M 3.03% 2
2023
Q4 		$82.2M Sell
140,954
-11,701
-8% -$6.83M 2.48% 6
2023
Q3 		$82M Sell
152,655
-7,420
-5% -$3.82M 2.76% 2
2023
Q2 		$75.1M Sell
160,075
-3,640
-2% -$1.53M 2.4% 4
2023
Q1 		$56.2M Sell
163,715
-3,339
-2% -$1.13M 1.93% 19
2022
Q4 		$61.1M Sell
167,054
-3,605
-2% -$1.28M 2.17% 11
2022
Q3 		$55.2M Buy
170,659
+1,560
+0.9% +$494K 2.13% 12
2022
Q2 		$54.8M Sell
169,099
-746
-0.4% -$224K 1.99% 15
2022
Q1 		$48.6M Buy
169,845
+11,120
+7% +$2.86M 1.45% 29
2021
Q4 		$43.8M Buy
+158,725
New +$40.2M 1.24% 34
2019
Q1 		– Sell
-15,000
Closed -$1.74M – 165
2018
Q4 		$1.74M Buy
+15,000
New +$1.68M 0.09% 88

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Bowen Hanes & Co's LLY Position: Q3 2026 in Review

Bowen Hanes & Co reduced its Eli Lilly (LLY) stake by 0.49% in Q3 2026, selling an estimated $667K and leaving 114,081 shares worth $132M. The position accounts for 2.98% of the portfolio, ranked #7.

Bowen Hanes & Co first reported a position in LLY in Q4 2018 and has held it in 21 quarters since. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Bowen Hanes & Co held 114,081 shares of Eli Lilly worth $132M as of Q3 2026.
  • Bowen Hanes & Co sold 565 Eli Lilly shares in Q3 2026, an estimated $667K.
  • Eli Lilly made up 2.98% of Bowen Hanes & Co's portfolio in Q3 2026, its #7 holding.
  • Bowen Hanes & Co first reported a position in Eli Lilly in Q4 2018 and has held it in 21 quarters since.
  • 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Bowen Hanes & Co's 13F filing for Q3 2026, filed 9 Nov 2026.